Can Smoking Cause Neuropathy? How It Affects Your Nerves

Smoking can cause neuropathy, and research across dozens of studies consistently links tobacco use with higher rates of nerve damage, worse nerve-related pain, and measurable changes to nerve structure and function. The connection runs through several pathways at once: direct chemical toxicity to nerve fibers, constricted blood flow that starves nerves of oxygen, amplified damage in people who already have conditions like diabetes, and even changes to how the brain processes pain signals. The picture that emerges from the evidence is that smoking is not just one risk factor among many but a particularly damaging one, because it hits nerves from multiple directions simultaneously.

How Tobacco Chemicals Directly Damage Nerve Tissue

Cigarette smoke contains thousands of chemical compounds, and several of them are directly toxic to nerve fibers. Nicotine, the most studied component, triggers oxidative stress in peripheral nerves. In animal research, nicotine exposure caused dose-dependent damage to the sciatic nerve, the large nerve running through the leg. The damage included increased scarring around the nerve (perineural fibrosis), breakdown of the myelin sheath that insulates nerve fibers, and signs that Schwann cells, the cells responsible for maintaining that insulation, were dying off. The blood vessels supplying the nerve also showed disrupted linings, meaning the protective barrier between the bloodstream and the nerve tissue was compromised.¹

It is not just nicotine itself that causes problems. Cotinine, the main metabolite your body produces when it breaks down nicotine, appears to worsen nerve degeneration on its own. When researchers looked at peripheral nerves exposed to cotinine, they found that it aggravated traumatic degeneration and promoted fibrosis. The Schwann cells in thick-myelinated fibers showed especially high grades of degeneration, along with swollen mitochondria, a hallmark of cells under severe oxidative stress.² This matters because cotinine stays in the body much longer than nicotine does, meaning nerve tissue is exposed to a damaging chemical for hours after each cigarette.

Smoke also delivers heavy metals like cadmium and lead directly into the body. These metals are established neurotoxicants on their own, and when they arrive alongside the particulate matter in smoke, their effects can stack. Research on nerve terminals found that smoke particles and lead produced additive damage, each causing membrane depolarization independently and combining to make the overall effect worse.³ In other words, the cocktail of toxins in each puff hits nerve cells from several angles at once.

Smoking and Diabetic Neuropathy

Diabetes is already the most common cause of peripheral neuropathy, and smoking makes it measurably worse. A large systematic review and meta-analysis pooling data from cohort, cross-sectional, and case-control studies found that smokers with diabetes face a meaningfully higher risk of developing diabetic peripheral neuropathy. Cohort studies put the increased risk at roughly 28 percent. Cross-sectional and case-control data told a similar story, with odds ratios ranging from about 1.29 to 1.48 depending on the study design.⁴

Those numbers represent risk on top of what diabetes itself already imposes. If you have diabetes and you smoke, you are not just dealing with the nerve damage from high blood sugar; you are layering on the vascular damage, oxidative stress, and direct nerve toxicity from tobacco. The combination is especially harsh because both conditions impair blood flow to small vessels, and peripheral nerves depend on those tiny blood vessels for oxygen and nutrients. When both insults hit at the same time, nerve fibers lose their supply lines faster than the body can repair them.

When Blood Vessels Fail the Nerves

Your peripheral nerves are not self-sufficient. They rely on a dense network of tiny blood vessels, called vasa nervorum, to deliver oxygen and glucose. Smoking systematically damages these vessels through atherosclerosis, endothelial dysfunction, and chronic inflammation. When blood flow to the nerves drops, the nerves start to malfunction and eventually die.

This plays out most visibly in peripheral artery disease. People with severe PAD have measurably slower peroneal nerve conduction velocity compared with people who have mild or no PAD, and the degree of ischemia-related changes in the lower-extremity nerves tracks directly with functional impairment.⁵ In plain terms, the worse your leg circulation gets, the worse your leg nerves perform, and smoking is the single strongest modifiable risk factor for PAD.

An extreme example of this vascular mechanism is Buerger’s disease, a condition in which small and medium-sized arteries and veins, especially in the hands and feet, become inflamed and clotted. Cigarette smoking has been identified as the primary cause. In parts of eastern Asia, this disease accounts for 40 to 60 percent of all peripheral vascular disease cases. The nerve damage follows the vascular damage: as arteries close off, the nerves they supply begin to fail, producing numbness, tingling, and pain in the extremities. The only treatment that reliably stops the disease from progressing is quitting smoking entirely.⁶

Damage to the Autonomic Nerves

Neuropathy is not limited to the nerves you can feel. Smoking also affects the autonomic nervous system, the branch that controls functions you do not consciously think about: heart rate, digestion, blood pressure regulation, sweating. Evidence of this shows up clearly in studies measuring heart rate variability, which is one of the most sensitive markers of autonomic nerve health.

A case-control study from central India found that chronic smokers had significantly higher resting heart rates and dramatically impaired heart rate variability compared to non-smokers. The measure called SDNN, which reflects overall autonomic tone, was reduced below a clinically concerning threshold in about 60 percent of smokers versus roughly 13 percent of non-smokers. The damage correlated with cumulative exposure: the more pack-years a person had smoked, the worse every autonomic marker performed.⁷

A separate cross-sectional study examining standard autonomic function tests found a similar pattern. Parasympathetic function tests, including expiration-to-inspiration ratio and the 30:15 ratio (a test of the heart rate response to standing up), were significantly impaired in smokers. At the same time, the sustained handgrip test, which reflects sympathetic function, also showed significant differences. The picture was one of broad autonomic dysfunction rather than damage to just one branch of the system.⁸

In daily life, autonomic neuropathy from smoking could contribute to dizziness when standing, abnormal sweating patterns, digestive irregularities, or an inability to properly regulate heart rate during exercise. These symptoms tend to be subtle and easy to attribute to other causes, which means they often go unrecognized as nerve damage.

Smoking, Pain Amplification, and Central Sensitization

Beyond damaging the nerves themselves, smoking appears to change how the nervous system processes pain. A systematic review covering 62 studies found that smoking was consistently linked with greater neuropathy prevalence and worse pain severity. The review suggested that smoking disrupts the body’s natural pain-control systems, including desensitizing certain receptors, suppressing the release of the body’s own pain-relieving chemicals, and altering stress-hormone pathways.⁹

Part of this may involve a phenomenon called central sensitization, where the spinal cord and brain become hypersensitive to pain signals, amplifying sensations that would otherwise be mild or ignorable. A web-based cross-sectional study found that current smoking was an independent risk factor for central sensitization, and heavier smoking exposure (measured by a cumulative index) correlated with higher sensitization scores.¹⁰ Animal research supports a plausible mechanism: prolonged nicotine exposure promoted sustained changes in pain-related proteins in both the spinal cord and peripheral nerve ganglia, the kinds of changes associated with developing and maintaining sensitized pain states.¹¹

This creates something of a vicious cycle for smokers with neuropathy. The nerve damage itself produces pain signals, and smoking simultaneously turns up the volume on those signals by making the central nervous system more reactive. Many smokers report that cigarettes temporarily relieve pain, which is true in the very short term because nicotine does have acute analgesic properties. But chronically, the effect reverses: the nervous system adapts by becoming more sensitive, and the smoker ends up in more pain between cigarettes than they would have been without smoking at all.

Carpal Tunnel Syndrome and Tobacco Use

Carpal tunnel syndrome is the most common entrapment neuropathy, and the question of whether smoking contributes to it has produced a surprisingly tangled body of evidence. Cross-sectional studies have consistently found that current smokers are more likely to have carpal tunnel syndrome, with pooled odds ratios around 1.5 to 2.0 depending on the analysis.¹² But a more recent meta-analysis that included prospective cohort studies found that the association weakened or disappeared when researchers used stricter study designs and adjusted for potential biases. Cohort studies showed no significant difference in carpal tunnel incidence between current and never smokers.¹³

A Mendelian randomization study, which uses genetic variants associated with smoking behavior to test for causal effects, pushed back against the idea that the link is purely coincidental. That analysis found that smoking initiation, current smoking status, and lifetime smoking exposure were all associated with increased risk of carpal tunnel syndrome, while never smoking was protective.¹⁴ The genetic approach is valuable because it sidesteps confounders like occupation and body weight that make observational studies hard to interpret.

The honest summary is that smoking likely does increase carpal tunnel risk to some degree, but the effect is modest enough that it gets muddied by other factors in observational data. If you smoke and already have risk factors for carpal tunnel, such as repetitive hand work or obesity, tobacco is probably making things incrementally worse. But it is not going to be the primary driver the way it can be for, say, Buerger’s disease.

Secondhand Smoke and Nerve Function

The nerve effects of tobacco are not limited to people who light up themselves. Research on women exposed to secondhand smoke found that passive smokers showed abnormal sympathetic nerve activity similar to that seen in active smokers. Specifically, their sympathetic nerve firing patterns became non-fluctuating, unlike the normal cycling seen in never-smokers, and their nerve response to a cold stress test was markedly exaggerated.¹⁵ Former smokers, interestingly, did not show this pattern, suggesting some degree of reversibility once exposure stops.

This is a relatively underexplored area, and most studies on smoking and neuropathy focus on active smokers. But the secondhand smoke findings are worth knowing, especially for people who live with heavy smokers. If passive exposure is enough to alter sympathetic nerve function, it may also contribute to subtler forms of autonomic dysfunction that are hard to attribute to a specific cause.

Does Quitting Actually Help?

This is the question that matters most for anyone who smokes and has neuropathy or wants to prevent it. The evidence, while still growing, points in a hopeful direction. A systematic review found that smoking cessation was significantly associated with a reduction in peripheral neuropathy at one year.⁹ The secondhand smoke research mentioned above also provides indirect evidence of reversibility, since former smokers no longer showed the sympathetic nerve abnormalities seen in current and passive smokers.¹⁵

That said, reversibility has limits. Nerve fibers that have already been destroyed do not regenerate quickly or completely, especially in older adults and people with diabetes. The vascular damage from years of smoking does not vanish overnight either. What quitting does is remove the ongoing insult: you stop piling on new damage, and the body gets a chance to stabilize and, in some cases, partially recover. The sooner someone quits, the more nerve function they are likely to preserve.

For people with diabetic neuropathy specifically, the case for quitting is especially strong given the roughly 28 to 48 percent added risk that smoking layers on top of diabetes.⁴ Removing that added risk is one of the few modifiable interventions available for a condition that otherwise has limited treatment options.

Why Small Fiber Neuropathy Remains an Open Question

One area where the evidence does not neatly fit the narrative involves small fiber neuropathy, which affects the thinnest nerve endings in the skin and typically produces burning pain, prickling sensations, or temperature sensitivity. An exploratory study that directly counted intraepidermal nerve fiber density, the gold standard test for small fiber neuropathy, found no statistically significant difference between smokers and non-smokers. Surprisingly, within each age group, smokers actually had slightly higher average nerve fiber counts than non-smokers, though the difference was not significant.¹⁶

This is a single small study, and the researchers described it as exploratory, so it would be wrong to conclude from it that smoking does not harm small fibers. But it does suggest that the relationship between smoking and nerve damage is not uniform across all nerve types. The most robust evidence links smoking to large-fiber neuropathy (the kind detected by nerve conduction studies), vascular neuropathy, and autonomic neuropathy. Whether small sensory fibers in the skin are equally vulnerable remains genuinely unclear, and more research with larger sample sizes would be needed to settle the question.

Nicotine Replacement and E-Cigarettes

If nicotine itself is part of the problem, an uncomfortable question follows: do nicotine replacement products and e-cigarettes carry some of the same nerve risks? Research on long-term nicotine exposure in airway cells found that nicotine alone, separate from the other chemicals in combusted tobacco, altered nerve growth factor signaling and increased the release of a pro-inflammatory molecule that plays a role in nerve function.¹⁷ The researchers cautioned against assuming nicotine products are benign replacements for smoking, particularly in people who already have airway or inflammatory conditions.

That said, nicotine replacement therapy removes the heavy metals, particulate matter, carbon monoxide, and thousands of other toxic compounds in cigarette smoke. Even if nicotine itself carries some nerve-related risk, the overall toxic burden drops enormously when someone switches from combusted tobacco to a clean nicotine source. For a smoker trying to protect their nerves, the calculus is clear: quitting entirely is best, but switching to nicotine replacement is still a large step in the right direction. The risk from nicotine alone is real but far smaller than the risk from the full package of cigarette smoke.

1
PubMed. Nicotine-induced oxidative stress alters sciatic nerve barriers in rat through modulation of ZO-1 & VEGF expression
2
Duzce Medical Journal. Cotinine Effects on Peripheral Nerve Injuries: An Experimental Study
3
PubMed. Multipollutant reciprocal neurological hazard from smoke particulate matter and heavy metals cadmium and lead in brain nerve terminals
4
PubMed Central. The association between smoking and diabetic neuropathy: a systematic review and meta-analysis
5
PubMed Central. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia
6
PubMed Central. Thromboangiitis Obliterans (Buerger’s Disease)-Current Practices
7
European Journal of Cardiovascular Medicine. Electrocardiographic Changes and Heart Rate Variability as Markers of Cardiac Autonomic Dysfunction in Chronic Smokers
8
PubMed Central. The Effect of Smoking on the Cardiovascular Autonomic Functions: A Cross Sectional Study
9
PubMed Central. A Systematic Review of Lifestyle Interventions for Neuropathy and Neuropathic Pain: Smoking Cessation
10
PubMed Central. Association between smoking and central sensitization pain: a web-based cross-sectional study
11
PubMed Central. Nicotine stimulates expression of proteins implicated in peripheral and central sensitization
12
PubMed. Smoking and carpal tunnel syndrome: a meta-analysis
13
PubMed Central. Is Smoking Associated with Carpal Tunnel Syndrome? A Meta-Analysis
14
Tobacco Induced Diseases. Smoking may be a risk factor for carpal tunnel syndrome: Insights from Mendelian randomization analysis
15
PubMed Central. Abnormal sympathetic nerve activity in women exposed to cigarette smoke: a potential mechanism to explain increased cardiac risk
16
Scientific Reports. Optical coherence tomography and histological assessment of cutaneous vasculature and neural changes in long-term smokers: an exploratory study
17
PubMed Central. Long term effects of cigarette smoke extract or nicotine on nerve growth factor and its receptors in a bronchial epithelial cell line